These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21178721)

  • 21. [Non-small cell lung cancer. New biomarkers for diagnostics and therapy].
    Kayser G
    Pathologe; 2015 Nov; 36 Suppl 2():189-93. PubMed ID: 26391246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update on biomarkers for kinase inhibitor response in non-small-cell lung cancer.
    Ku BM; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
    Expert Rev Mol Diagn; 2017 Oct; 17(10):933-942. PubMed ID: 28838271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancer.
    Ellis PM; Blais N; Soulieres D; Ionescu DN; Kashyap M; Liu G; Melosky B; Reiman T; Romeo P; Shepherd FA; Tsao MS; Leighl NB
    J Thorac Oncol; 2011 Aug; 6(8):1379-91. PubMed ID: 21709590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015.
    García-Campelo R; Bernabé R; Cobo M; Corral J; Coves J; Dómine M; Nadal E; Rodriguez-Abreu D; Viñolas N; Massuti B
    Clin Transl Oncol; 2015 Dec; 17(12):1020-9. PubMed ID: 26691657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Updates Regarding Biomarker Testing for Non-Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable.
    Kim ES; Roy UB; Ersek JL; King J; Smith RA; Martin N; Martins R; Moore A; Silvestri GA; Jett J
    J Thorac Oncol; 2019 Mar; 14(3):338-342. PubMed ID: 30709747
    [No Abstract]   [Full Text] [Related]  

  • 26. Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Kozower BD; Larner JM; Detterbeck FC; Jones DR
    Chest; 2013 May; 143(5 Suppl):e369S-e399S. PubMed ID: 23649447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of quality of life in patients with non-small-cell lung cancer.
    Camps C; del Pozo N; Blasco A; Blasco P; Sirera R
    Clin Lung Cancer; 2009 Mar; 10(2):83-90. PubMed ID: 19362950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-small cell lung cancer.
    Ettinger DS; Akerley W; Borghaei H; Chang AC; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Ganti AK; Govindan R; Grannis FW; Horn L; Jahan TM; Jahanzeb M; Kessinger A; Komaki R; Kong FM; Kris MG; Krug LM; Lennes IT; Loo BW; Martins R; O'Malley J; Osarogiagbon RU; Otterson GA; Patel JD; Pinder-Schenck MC; Pisters KM; Reckamp K; Riely GJ; Rohren E; Swanson SJ; Wood DE; Yang SC; Hughes M; Gregory KM;
    J Natl Compr Canc Netw; 2012 Oct; 10(10):1236-71. PubMed ID: 23054877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Executive summary of the SEPAR recommendations for the diagnosis and treatment of non-small cell lung cancer.
    Villar Álvarez F; Muguruza Trueba I; Belda Sanchis J; Molins López-Rodó L; Rodríguez Suárez PM; Sánchez de Cos Escuín J; Barreiro E; Borrego Pintado MH; Disdier Vicente C; Flandes Aldeyturriaga J; Gámez García P; Garrido López P; León Atance P; Izquierdo Elena JM; Novoa Valentín NM; Rivas de Andrés JJ; Royo Crespo Í; Salvatierra Velázquez Á; Seijo Maceiras LM; Solano Reina S; Aguiar Bujanda D; Avila Martínez RJ; de Granda Orive JI; de Higes Martinez E; Diaz-Hellín Gude V; Embún Flor R; Freixinet Gilart JL; García Jiménez MD; Hermoso Alarza F; Hernández Sarmiento S; Honguero Martínez AF; Jimenez Ruiz CA; López Sanz I; Mariscal de Alba A; Martínez Vallina P; Menal Muñoz P; Mezquita Pérez L; Olmedo García ME; Rombolá CA; San Miguel Arregui I; de Valle Somiedo Gutiérrez M; Triviño Ramírez AI; Trujillo Reyes JC; Vallejo C; Vaquero Lozano P; Varela Simó G; Zulueta JJ
    Arch Bronconeumol; 2016 Jul; 52(7):378-88. PubMed ID: 27237592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxic markers in non-small cell lung cancer (NSCLC) - A review.
    Xu FX; Zhang YL; Liu JJ; Zhang DD; Chen HB
    Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):849-52. PubMed ID: 27010140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in diagnosis and treatment and whole process management of anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer].
    Liu X; Chen J
    Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):1-4. PubMed ID: 25877310
    [No Abstract]   [Full Text] [Related]  

  • 32. From Uniplex to Multiplex Molecular Profiling in Advanced Non-Small Cell Lung Carcinoma.
    Ileana EE; Wistuba II; Izzo JG
    Cancer J; 2015; 21(5):413-24. PubMed ID: 26389767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant and Adjuvant Therapy for Non-Small Cell Lung Cancer.
    Chuang JC; Liang Y; Wakelee HA
    Hematol Oncol Clin North Am; 2017 Feb; 31(1):31-44. PubMed ID: 27912832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
    Cui D; Yu CH; Liu M; Xia QQ; Zhang YF; Jiang WL
    Tumour Biol; 2016 Mar; 37(3):4127-34. PubMed ID: 26490983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular predictive and prognostic markers in non-small-cell lung cancer.
    Coate LE; John T; Tsao MS; Shepherd FA
    Lancet Oncol; 2009 Oct; 10(10):1001-10. PubMed ID: 19796752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of advanced non-small cell lung cancer in the elderly.
    Sequist LV; Fidias P
    Semin Respir Crit Care Med; 2005 Jun; 26(3):289-97. PubMed ID: 16052430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recommendations for the analysis of ALK gene rearrangements in non-small-cell lung cancer: a consensus of the Italian Association of Medical Oncology and the Italian Society of Pathology and Cytopathology.
    Marchetti A; Ardizzoni A; Papotti M; Crinò L; Rossi G; Gridelli C; Barberis M; Maiorano E; Normanno N; Taddei GL; Scagliotti G; Clemente C; Pinto C
    J Thorac Oncol; 2013 Mar; 8(3):352-8. PubMed ID: 23407559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meeting report: 2nd meeting of the European Thoracic Oncology Platform (ETOP).
    Stahel R; Baas P; Faivre-Finn C; Dooms C; Passlick B; Mazières J; Cappuzzo F; Früh M; Sorensen JB; Blackhall F; Taron M; Gridelli C; O'Byrne K; Rosell R
    Lung Cancer; 2010 Apr; 68(1):121-4. PubMed ID: 20138388
    [No Abstract]   [Full Text] [Related]  

  • 39. [Management of nonresectable non-small cell lung cancer. Recommendations of the American Society of Clinical Oncology (ASCO)].
    Bompas E; Freyer G; Trillet-Lenoir V
    Bull Cancer; 1998 Feb; 85(2):125-7. PubMed ID: 9752328
    [No Abstract]   [Full Text] [Related]  

  • 40. Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer.
    Morgensztern D; Pennell NA; Subramanian J; Govindan R
    Clin Lung Cancer; 2011 Mar; 12(2):94-9. PubMed ID: 21550555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.